James T. Parsons
CIK 1759855 · Chief Financial Officer · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$683.5K
Companies
3
Total Filings
19
Lifetime Open-Market Net
-$115.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-02 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2022-01-03 | DMAC | Grant (A) | +16,773 | $60.0K | EDGAR |
| 2021-11-19 | — | Disp (D) | — | $0 | |
| 2021-07-16 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2021-01-12 | Trillium Therapeutics Inc. (TRIL) Delisted | Mixed | — | -$72.7K | EDGAR |
| 2021-01-04 | DMAC | Grant (A) | +7,745 | $63.7K | EDGAR |
| 2020-06-02 | DMAC | Grant (A) | +8,102 | $37.2K | EDGAR |
| 2019-06-26 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2018-12-11 | DMAC | Buy (P) | +2,250 | $9.0K | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.